Modern Family Star Eric Stonestreet Challenges Americans to Support the Cancer Community & Learn about Immuno-Oncology Resear...
June 28 2017 - 6:59AM
Business Wire
- Dallas Cowboys quarterback Dak Prescott
and actress/author Tia Mowry join Eric Stonestreet, Bristol-Myers
Squibb and 30 cancer advocacy groups for the third year of the
campaign
- Ready. Raise. Rise. is a social
movement that empowers people to join the fight against cancer by
supporting the cancer community, honoring loved ones and learning
about advances in cancer research
Eric Stonestreet of television’s hit comedy “Modern Family” and
new reality competition series, “The Toy Box,” is once again
lending his star power to the Ready. Raise. Rise. campaign,
challenging people across the country to show their support for the
cancer community and spread the word about immuno-oncology – a
rapidly evolving area of cancer research that aims to offer renewed
hope and the potential of a longer life to people with various
forms of cancer.
This Smart News Release features multimedia.
View the full release here:
http://www.businesswire.com/news/home/20170628005220/en/
Ready. Raise. Rise. Spokespeople Tia
Mowry, Eric Stonestreet and Dak Prescott (Photo: Business Wire)
“Anyone who’s been touched by cancer knows it’s a battle – one
that involves patients, and often a community of family, friends,
doctors, nurses, scientists and advocates around them. I know this
firsthand from when my mom was diagnosed with cancer twice, and
when my grandmother battled this disease three times,” said
Stonestreet. “I’m joining Ready. Raise. Rise. again to bring
us together as a community and take action in the fight against
cancer. I’ve even recruited my friends Dak Prescott and Tia Mowry
to help encourage all of America to get involved in the challenge.
We can fight cancer together.”
“Cancer incidence rates are increasing worldwide, and in the
United States cancer has replaced heart disease as the leading
cause of death in 22 states,” said Morganna Freeman, DO, FACP,
Associate Director, Melanoma and Cutaneous Oncology Program, The
Angeles Clinic and Research Institute, an affiliate of Cedars-Sinai
in Los Angeles. “Fighting cancer calls for advancements in
research, such as immuno-oncology, which seek to harness the body’s
own immune system to help identify and attack cancer cells with the
ultimate goal of improving survival and quality of life for people
with cancer. It also calls for each of us to play a role in the
fight against cancer, whether that be supporting a loved one,
providing medical care, contributing to advocacy groups or
researching for a cure.”
A new Ready. Raise. Rise. survey of 2,500 American adults
revealed gaps in knowledge about an advancement in cancer research,
immuno-oncology, and reinforced the importance of community support
for people impacted by cancer. According to the results:
- The overwhelming majority of Americans
(88%) say that cancer research is important to them, yet few (25%)
are knowledgeable about a rapidly evolving area – immuno-oncology
research
- In fact, only four in 10 people are
aware that the immune system can help fight some cancers
- A promising finding, however, showed
83% of Americans want to know more about how the immune system
fights cancer
- When it comes to building a strong
network when fighting cancer, 66% of those impacted by the disease
agree that having a strong support system would be most helpful to
them
The Ready. Raise. Rise. challenge is a call to action to
all Americans to raise money for cancer advocacy groups and spread
the word about immuno-oncology research. When people visit
ReadyRaiseRise.com, they can take socially-driven actions, like
raising and sharing a virtual flag on behalf of a loved one touched
by cancer, sending a message of support and spreading the word
about immuno-oncology research. In taking these actions, people can
earn points for the participating advocacy group of their choice.
For every point earned by July 31, 2017, Bristol-Myers Squibb will
donate $1 up to a maximum $150,000 to be distributed equally among
participating advocacy groups.
“Through our continued work within immuno-oncology research in
multiple types of cancer, we ultimately strive to improve outcomes
for patients, such as survival and quality of life. Ready.
Raise. Rise. helps bring together the cancer community to
spread awareness of research developments and provide a meaningful
platform to honor everyone who plays a role in fighting this
disease,” said Teresa Bitetti, senior vice president, U.S.
Oncology, Bristol-Myers Squibb.
About Ready. Raise. Rise.
Ready. Raise. Rise. is a campaign sponsored by
Bristol-Myers Squibb to raise awareness of immuno-oncology, a
rapidly evolving area of research, and bring people together to
participate in the fight against cancer by celebrating and honoring
loved ones touched by the disease and supporting the cancer
community. Thirty cancer advocacy groups participate in Ready.
Raise. Rise. For more information, visit
ReadyRaiseRise.com.
Immuno-Oncology at Bristol-Myers Squibb
Bristol-Myers Squibb is leading research in an innovative field
of cancer research and treatment known as immuno-oncology, which
seeks to work directly with the body’s immune system to fight
cancer. The company is exploring a variety of compounds and
immunotherapeutic approaches for patients with different types of
cancer, including researching the potential of combining
immuno-oncology agents that target different pathways in the
treatment of cancer.
Bristol-Myers Squibb is committed to advancing the science of
immuno-oncology, with the goal of changing survival expectations
and the way patients live with cancer.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose
mission is to discover, develop and deliver innovative medicines
that help patients prevail over serious diseases. For more
information about Bristol-Myers Squibb, visit us
at BMS.com or follow us on LinkedIn, Twitter,
YouTube and Facebook.
About the Survey
The survey was conducted by Kantar TNS, one of the world’s
largest research agencies. Participants in the nine-question,
self-administered online omnibus survey were a
nationally-representative sample of 2,500 Americans 18 years of age
and older. The survey was conducted from February 23-26, 2017. The
margin of sampling error for total Americans at the 95% level of
confidence is ±2.0%. The margin of sampling error for
Americans who are cancer sufferers/survivors at the 95% level of
confidence is ±7.9%. Data are weighted to reflect accurate
representation of the population.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170628005220/en/
Media:Bristol-Myers SquibbCaitlin Craparo,
609-302-3080Caitlin.Craparo@bms.com
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Apr 2023 to Apr 2024